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Pseudomonas aeruginosa AC869, a 3,5-dichlorobenzoate degrader, is a mouse pathogen and has a reported
50% lethal dose (LD50) of 1.05 3 107 CFU when given intranasally to C3H/HeJ mice (S. E. George, M. J. Kohan,
M. I. Gilmour, M. S. Taylor, H. G. Brooks, J. P. Creason, and L. D. Claxton, Appl. Environ. Microbiol. 59:3585–
3591, 1993). AC869 was serotyped as O6 when grown in CD-1 mouse cecal and lung mucus but could not be
assigned an O serotype when grown in Luria broth (LB). After growth in mouse cecal mucus, a less virulent
mutant, AC869-11, was isolated from AC869 by using bacteriophage E79, which adsorbs to the O side chain of
lipopolysaccharide (LPS). AC869-11 produced significantly less O antigen on its LPS than AC869 when grown
in mouse lung and cecal mucus. The mutant also produced half the amount of exoenzyme S and 16-fold less
extracellular protease than AC869 and was more sensitive than its parent to a number of antibiotics when
grown either in LB or in mouse lung mucus. AC869-11 had a ninefold higher LD50 than AC869 in CD-1 mice
when administered intranasally. AC869-11 was found in the lungs, small intestine, cecum, and large intestine
in numbers at least 100-fold below AC869, 3 h after intranasal exposure of mice to a sublethal dose of the two
strains. Moreover, AC869-11 induced a decreased pulmonary inflammatory response relative to AC869. In
contrast to AC869, AC869-11 did not translocate to the mesenteric lymph nodes, liver, and spleen following a
sublethal dose. Despite attenuation, AC869-11 grew as well as AC869 with 3,5-dichlorobenzoate as the sole
carbon and energy source. However, although AC869-11 survived in 3,5-dichlorobenzoate-contaminated soil as
well as AC869 for 1 week, it failed to survive as well thereafter. These results suggest the possibility that
mutations that lead to pulmonary attenuation of P. aeruginosa in mice also lead to weakness in the environment, despite such mutants maintaining the ability to degrade toxic substances under laboratory conditions.
sole source of carbon and energy but which has been found to
be pathogenic for mice when administered intranasally (50%
lethal dose [LD50] 5 1.05 3 107 CFU) (11). In the present
study, AC869 was used as a model to determine whether it
could be attenuated without impairing its ability to degrade
3,5-dichlorobenzoate, to grow in common laboratory media,
and to survive in 3,5-dichlorobenzoate-contaminated soil. Our
approach was to look for new antigens associated with growth
in mouse lung and cecal mucus preparations in vitro, to make
mutants that no longer make these antigens, and to test such
mutants for changes in virulence, ability to degrade 3,5-dichlorobenzoate, and ability to survive in 3,5-dichlorobenzoate-contaminated soil.

Members of the genus Pseudomonas are used for environmental applications as agricultural biopesticides (26), as detoxifiers of chemicals (19), and in prevention of ice nucleation
on plants (20) because of their effectiveness in biocontrol and
versatile substrate utilization abilities (19). For obvious reasons, the strains to be released into the environment must be
strong, competitive organisms. Unfortunately, strong, competitive pseudomonads may be opportunistic human pathogens
capable of causing disease, especially in immunosuppressed
hosts and patients with leukemia or cystic fibrosis (2, 3, 12, 27).
Human exposure to these microorganisms may occur during
production or application. Because a high concentration of
these microorganisms may be found in the air and water, exposure and subsequent disease may occur through inhalation and
ingestion. Clearly, strong, competitive Pseudomonas strains
which are still capable of performing the task for which they
were designed but which are unable to colonize the lung tissue
or the intestines of humans and animals should be constructed
in order to minimize the risk of opportunistic infections.
Pseudomonas aeruginosa AC869 is an environmental strain
that has been engineered to utilize 3,5-dichlorobenzoate as the

MATERIALS AND METHODS
Bacteria and bacteriophage. P. aeruginosa AC869 was engineered to utilize
3,5-dichlorobenzoate as a sole carbon and energy source (5). P. aeruginosa PAO1
has been described previously (13). The bacteriophage E79, which adsorbs to the
O side chain of lipopolysaccharide (LPS) (16), and P. aeruginosa IATS 06, the
host of bacteriophage E79, were provided by A. M. Kropinski from Queen’s
University, Kingston, Ontario, Canada.
Laboratory media and antibiotics. The strains were routinely grown at 378C in
Luria broth (LB) and plated on L agar, which is LB containing 12% Bacto Agar
(Difco, Detroit, Mich.). M9 minimal medium was prepared as described by
Miller (23). For measurement of exoenzyme S production, strains were grown in
Vogel-Bonner minimal medium (29). All antibiotics were purchased from Sigma
(St. Louis, Mo.).
Animals. Five- to eight-week-old CD-1 mice, used as a source of lung and cecal
mucus, were obtained from Charles River Laboratories (Wilmington, Mass.).
Food (Agway Prolab Rat/Mouse/Hamster 3000 Formula) and deionized water
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following administration of bacteria intranasally, as described above, mice were
sacrificed by CO2 asphyxiation and were dissected aseptically. The lungs, small
intestine, cecum, large intestine, spleen, liver, and mesenteric lymph nodes were
removed from each mouse and homogenized in 5 ml of PBS. The homogenates
were diluted in PBS and plated for enumeration of P. aeruginosa on Pseudomonas isolation agar (Difco) supplemented with 50 mg of kanamycin per ml. This
level of kanamycin allowed a 100% plating efficiency of AC869 and AC869-11
relative to unsupplemented Pseudomonas isolation agar. Plates were counted
following 48 h of incubation at 378C. Representative colonies were subcultured,
and antibiotic sensitivity was determined by using antibiotic disks (BBL Microbiology Systems, Cockeysville, Md.) to eliminate contaminants in the enumeration of the strain administered. For each experiment, three animals per treatment per time point were used. Duplicate experiments were performed, and the
data presented are from both experiments.
Pulmonary inflammatory response. Sets of four CD-1 mice were sacrificed by
injecting sodium pentobarbital (150 mg per kg of body weight) intraperitoneally
at 1, 2, 5, 7, and 14 days following treatment, and cells were collected from the
lungs by bronchoalveolar lavage. Each trachea was cannulated, and the lungs
were flushed three times with warm saline (35 ml per kg). Cytospin preparations
were stained with Diff-Quick (Baxter Diagnostics, Inc., McGaw Park, Ill.), and
alveolar macrophages, polymorphonuclear leukocytes, and lymphocytes were
determined by examining 200 representative cells.
Preparation of antisera. Antisera were prepared against P. aeruginosa AC869
grown in LB, CM, and LM. Briefly, 25 ml of P. aeruginosa AC869 grown in LB,
CM, and LM was washed twice in HH buffer, resuspended in 0.5 ml of 0.85%
saline containing 0.3% formalin, mixed with 0.7 ml of incomplete Freund’s
adjuvant, and injected into rabbits intramuscularly and subcutaneously (0.1 to 0.2
ml per site). Rabbits were then boosted at 2 months and subsequently bled 2
weeks after the last injection. Sera raised against LB-grown, CM-grown, and
LM-grown AC869 will be referred to as LB-anti-AC869, CM-anti-AC869, and
LM-anti-AC869 sera, respectively.
KDO assay. 2-Keto-3-deoxyoctonate (KDO) was determined by the method of
Karkhanis et al. (15). The ammonium salt of KDO (Sigma Chemical Co.) was
used as the standard.
Isolation of LPS. Cells were resuspended in 1 ml of PBS and vortexed, and
tubes were incubated at 608C for 30 min. The suspension was centrifuged at
11,750 3 g for 30 min. One hundred microliters of the supernatant was added to
100 ml of sample buffer (62.5 mM Tris-HCl [pH 6.8], 10% glycerol, 2% [wt/vol]
sodium dodecyl sulfate [SDS], 0.05% [wt/vol] 2-B-mercaptoethanol, 0.00125%
[wt/vol] bromophenol blue), and the mixture was boiled for 10 min. The rest of
the supernatant was stored at 48C. Fifty microliters of the boiled sample was
added to 10 ml of a protease K solution (2.5 mg of protease K per ml of sample
buffer) and was then incubated at 608C for 60 min, the mixture was centrifuged
at 16,000 3 g for 30 min, and an appropriate volume of supernatant (0.03 mg of
KDO) was applied to an SDS-polyacrylamide gel electrophoresis (PAGE) gel for
analysis. This method is used routinely for extracting LPS from small numbers of
CFU at the Statens Seruminstitut, Copenhagen, Denmark (26a).
SDS-PAGE. One-dimensional SDS-PAGE was performed at 200 V for 30 min
in a Mini-Protean II electrophoresis cell (Bio-Rad Laboratories, Richmond,
Calif.) with 4% stacking gels and 12% separating gels.
Silver staining of LPS. A modification of a sensitive silver staining technique
for detecting LPSs in polyacrylamide gels was used (8). Briefly, gels were fixed in
40% ethanol–5% acetic acid in a clean glass dish overnight, and fixing solution
was then replaced with 0.7% periodic acid in 40% ethanol–5% acetic acid for 30
min. Silver staining was then performed according to package instructions with
the Bio-Rad silver stain kit (Bio-Rad Laboratories).
Immunoblotting. Immunoblots of SDS-PAGE gels were performed as described in the package instructions from Zymed Laboratories, Inc. (South San
Francisco, Calif.). Briefly, gels were blotted to 0.45-mm-pore-size nitrocellulose
membranes (Bio-Rad Laboratories) at 60 V for 20 min (Mini-Transblot electrophoretic transfer cell apparatus; Bio-Rad Laboratories), incubated in Tris-buffered saline (TBS) (0.15 M NaCl, 0.05 M Tris-HCl, pH 7.2) with 3% skim milk for
30 min at room temperature, and then reacted with a 1:1,000 dilution of a rabbit
antiserum for 1 h. The blots were then incubated in a 1:200 dilution of goat
anti-rabbit immunoglobulin G-gold conjugate (Zymed Laboratories, Inc.) for 2 h
at room temperature. Reactivity was detected by enhancement with a SilvEnhance Blot kit (Zymed Laboratories, Inc.). Antisera were diluted in TBS containing 0.05% Tween 20, 0.4% gelatin, and 0.1% bovine serum albumin. Membranes were washed in TBS containing 0.05% Tween 20.
Antibiotic sensitivity. A series of twofold dilutions of each antibiotic were
made in LB or LM (1 mg of protein per ml) to obtain the appropriate concentrations. Strains to be tested were grown overnight by shaking in LB at 378C.
Cells were collected after centrifugation and were then washed twice with sterile
HH buffer. Approximately 105 CFU per ml was inoculated into each tube containing an antibiotic and to one tube not containing an antibiotic, which served
as the control. After 24 h of standing incubation at 378C, cells were diluted and
plated on L agar plates. Plates were incubated from 20 to 24 h at 378C prior to
counting. We define the MIC as the lowest concentration of an antibiotic that
reduced growth by at least 1 order of magnitude relative to the untreated culture
and the MBC as the lowest concentration of an antibiotic that resulted in CFU
per milliliter at least 1 order of magnitude lower than that at inoculation. All
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were provided ad libitum, and the mice were housed in polycarbonate cages
containing pine shavings. For LD50 and clearance studies, 35-day-old male CD-1
mice were fed Purina Rodent Chow 5001 (Purina Mills, Inc., St. Louis, Mo.).
Deionized water was provided ad libitum, and the mice were housed in polycarbonate cages (five mice per cage) containing pine shavings. The animals were
quarantined for 10 days prior to treatment.
Mucus isolation. Thirty mice were sacrificed by CO2 asphyxiation and were
dissected aseptically. A small incision was made in the trachea, and a 1-in. (2.54
cm) 22-gauge feeding needle was introduced into the airway. Heavy thread was
tied around the trachea at the tip of the needle to prevent leakage. A 10-ml
syringe containing 5 ml of sterile HEPES-Hanks buffer, pH 7.4 (HH), was
connected to the needle, and the lungs were inflated and deflated several times
with HH. Backflushed HH was collected and called crude lung mucus. Ceca were
then removed and placed in sterile HH. Ceca were nicked at each end, and the
luminal contents were removed by gentle scraping with a rubber spatula. The
ceca were then transferred to a second petri dish and gently agitated in sterile
HH to remove any debris. Scraping of the walls of the ceca was conducted in a
third petri dish containing 5 ml of sterile HH. This scraping removed the mucus
layer, which remained soluble in HH (7). The crude lung and cecal mucus
preparations were then centrifuged at 12,000 3 g for 10 min followed by a
27,000 3 g centrifugation of the supernatant for 15 min. The pellets contained
cellular, tissue, and fecal contaminants. The supernatants from cecal mucus and
lung mucus preparations will be referred to as CM and LM, respectively. All
centrifugations were carried out at 48C, and mucus preparations were placed on
ice during processing. CM and LM (1 mg of protein per ml) were then sterilized
in a sterile plastic petri dish for 15 min with UV light (254 nm). The UV box
contained three 15-W UV bulbs both on the top and at the bottom of the plates.
The distance of the UV source from the top and from the bottom of the plates
was 12 and 5 cm, respectively. The UV bulb in the middle of each row of bulbs
was 8 cm from its neighboring bulb on each side.
Growth in mucus. For immunoblotting experiments, P. aeruginosa strains,
grown by shaking in LB at 378C overnight, were washed twice in sterile HH and
resuspended in sterile HH at the same concentration. They were then diluted in
sterile HH and inoculated at about 104 CFU per ml into LB, CM (1 mg of protein
per ml), and LM (1 mg of protein per ml). The cultures were incubated standing
at 378C for 24 h, and cells were harvested by centrifugation at 12,000 3 g for 10
min, washed twice in HH, and used either for whole cell immunoblots or for LPS
extractions as described below. For determination of growth rates, strains grown
by shaking in LB at 378C overnight were washed twice in sterile HH and diluted
in sterile HH, and each was inoculated at about 105 CFU per ml into LB, CM (1
mg of protein per ml), and LM (1 mg of protein per ml). The cultures, incubated
at 378C standing for 0, 3, 6, 9, and 24 h, were diluted and plated on L agar plates.
Plates were incubated from 20 to 24 h at 378C prior to counting.
Protein assay. The protein concentration in mucus or in P. aeruginosa preparations was determined by the Bio-Rad protein assay (Bio-Rad, Rockville
Center, N.Y.), which is based on the method of Bradford (4). Assays were
performed according to package instructions with bovine serum albumin as the
standard.
Bacteriophage E79. High-titered bacteriophage E79 stocks were obtained as
follows. A series of 10-fold dilutions of E79 were mixed with 3 ml of Luria soft
agar (7 g of agar per liter) at 488C, 3 drops of P. aeruginosa IATS 06 overnight
culture was added to each soft agar tube and mixed, and the mixtures were
poured onto L agar plates. E79 was collected by washing plates containing
confluent plaques with 5 ml of LB after incubation at 308C overnight. The
collected mixture was then centrifuged at 12,000 3 g for 10 min, and the titer of
the supernatant containing phage E79 was determined.
Isolation of bacteriophage E79-resistant mutants of P. aeruginosa AC869.
P. aeruginosa AC869 was grown in CM at 378C without shaking. One-hundredmicroliter aliquots of the culture in 3-ml aliquots of Luria soft agar were mixed
with 100-ml aliquots of phage E79 (1010 PFU per ml), which had been shown
previously to interact with the LPS of smooth PAO1 strains (14, 16), and the
mixtures were then poured on L agar plates. After 24 h of incubation at 378C,
several colonies were selected and purified by streaking. All selected E79-resistant colonies were identified as P. aeruginosa by streaking on P. aeruginosa
isolation agar (Difco) and use of API 20E strips (Analytab Products, Plainview,
N.Y.). E79-resistant colonies were not observed when 100-ml aliquots of phage
E79 in Luria soft agar were poured on L agar plates.
Intranasal exposure and LD50s. Strains were grown in LB by shaking at 378C
overnight, the animals were anesthetized with methoxyfluorane in a desiccator
jar, and 50 ml of phosphate-buffered saline (PBS) or 50 ml of a cell suspension
was injected into the nasal cavity of each mouse with a 2.54-cm, 22-gauge feeding
needle. Mice were observed for 14 days following infection. All deaths occurred
by day 4, after which mice that survived became increasingly healthy as determined by general appearance and increase in weight. LD50s were determined by
treating five animals per dose of bacteria. LD50s were calculated following linear
regression analysis of a semilogarithmic plot of the mortality data.
Enumeration of administered bacterial strains obtained from lungs, small
intestine, cecum, large intestine, spleen, liver, and mesenteric lymph nodes.
Strains were grown in yeast extract-tryptone broth (11) to prepare the suspensions used for administration to mice. Enumeration of these suspensions was
done on yeast extract-tryptone agar (1.5%) following dilution in Dulbecco PBS
(GIBCO Laboratories, Grand Island, N.Y.). At 3 h and 1, 2, 5, 7, 10, and 14 days
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FIG. 1. Immunoblots of AC869 whole cells probed with CM-anti-AC869
sera. AC869 was grown in LB, CM, and LM. Whole cells (15 mg of protein) or
mucus (15 mg of protein), subjected to SDS-PAGE, was probed on blots with
CM-anti-AC869 serum. Lane 1, protein standards; lane 2, AC869 grown in LB;
lane 3, AC869 grown in CM; lane 4, AC869 grown in LM; lane 5, CM; lane 6,
LM. Numbers on the left denote protein standards in kilodaltons.

Plates were incubated at 378C for 18 to 24 h prior to counting. This experiment
was repeated once with essentially the same result as presented here. Soil samples were sterilized once each day for 4 consecutive days in 100-g aliquots in
250-ml Erlenmeyer flasks prior to inoculation.

RESULTS
Immunoblotting of P. aeruginosa AC869 whole cells probed
with anti-AC869 sera. When equal amounts of protein from
LB-grown, CM-grown, and LM-grown cells were examined by
immunoblotting, a stepladder configuration was observed between 35 and 70 kDa in CM-grown cells (Fig. 1, lane 3) and
LM-grown cells (Fig. 1, lane 4) but not in LB-grown cells (Fig.
1, lane 2) probed with CM-anti-AC869 serum or LM-antiAC869 serum (not shown). The AC869 anticecal serum was
consistently stronger and therefore was used throughout this
study. The stepladder configurations, reminiscent of LPS (22),
were not observed when the same preparations were probed
with LB-anti-AC869 serum (not shown). Since the CM-antiAC869 serum did not cross-react with CM (Fig. 1, lane 5) and
LM (Fig. 1, lane 6), the stepladder configuration was clearly
due to P. aeruginosa AC869.
Silver staining and O serotyping of P. aeruginosa AC869
LPS. LPS purified from AC869 grown in LB, CM, and LM was
subjected to SDS-PAGE and silver stained. Presumptive O
side chain in high-molecular-weight clusters of bands was associated with AC869 LPS isolated from CM- and LM-grown
cells (Fig. 2, lanes 3 and 4), but high-molecular-weight clusters
were not observed in the same amount of LPS isolated from
LB-grown cells (Fig. 2, lane 2). This suggested that, when
grown in CM or LM, AC869 synthesized far more O side chain
than when AC869 was grown in LB. In support of this view,
AC869 grown in both CM and LM was serotyped as O6
whereas the same strain grown in LB could not be assigned an
O serotype when tested with standard O serotyping sera.
Immunoblots of LPS isolated from P. aeruginosa AC869
probed with CM-anti-AC869 serum. LPS isolated from AC869
grown in LB, CM, and LM was subjected to SDS-PAGE and
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experiments were repeated at least once. Results of typical experiments are
shown.
Extracellular protease activity. Strains were grown in 0.5 ml of LB at 378C
standing for 24 h to about 109 CFU per ml and centrifuged at 8,000 3 g for 10
min. Cell-free LB supernatants were collected after seven successive centrifugations at 8,000 3 g for 10 min. Ten microliters of supernatants and twofold serial
dilutions of supernatants were pipetted onto casein agar plates (nutrient agar
[Difco] plus 1% skim milk powder). Casein agar plates were inspected for
protease activity (clear zones) after 16 h of incubation at 378C. All experiments
were repeated once, and three replicates were performed for each experiment.
Culture conditions for exoenzyme S production. Bacterial cultures were grown
on Vogel-Bonner minimal medium (29) at 378C for 18 to 24 h. For maximal
exoenzyme S production, deferrated Trypticase soy broth (10-ml culture volume)
with 100 mM monosodium glutamate, 1% glycerol, and 10 mM nitrilotriacetic
acid (NTA) was inoculated with colonies from minimal medium plates and
shaken at 328C for 12 to 14 h. As exoenzyme S production is severely reduced
when P. aeruginosa is grown in the absence of NTA (28), enzyme activity was also
assessed under these growth conditions as a negative control.
Exoenzyme S ADP-ribosyltransferase assay. Exoenzyme S activity was quantitated by ADP ribosylation of the target protein soybean trypsin inhibitor
(SBTI) as described previously (10). Briefly, reaction mixtures contained 200
mM sodium acetate (pH 6.0), 30 mM soybean trypsin inhibitor, 30 mM adenylate32
P-NAD (specific activity, 0.1 Ci/mmol; New England Nuclear), 2 mg of wheat
germ extract (source for factor-activating exoenzyme S) or (factor-activating
exoenzyme S) (6), and titrations of spent culture medium as a source for the
enzyme. The total reaction volume was 40 ml. Enzyme reaction mixtures were
incubated at 258C for 30 min, and reactions were stopped by the addition of
SDS-PAGE sample buffer containing 2-mercaptoethanol. A portion of the reaction was analyzed by SDS–13.5% PAGE. To visualize the SBTI band, the gel
was stained with Coomassie blue, destained, and dried. The band corresponding
to SBTI was cut from the dried gel, and the incorporation of [32P]ADP-ribose
from NAD was measured by scintillation counting. Data are expressed as units
of activity. One unit of activity is defined as 1 pmol of [32P]ADP-ribose incorporated into SBTI per ml of spent culture medium per min per absorbance at 540
nm (A540) of the culture at the time of harvest.
Antigen preparation for immunoblot analysis of exoenzyme S. Cultures were
grown for maximal exoenzyme S production and harvested in stationary phase.
Whole-culture samples (300 ml), which included both cells and spent medium,
were sonicated for 45 s, 50% duty cycle, at a power setting of three, with a
Branson Model 200 microtip sonicator (Danbury, Conn.). To obtain a cell lysate,
free of spent medium, 300 ml of culture was subjected to a brief centrifugation
(12,000 3 g, 2 min, 48C). The supernatant material was discarded, and the cell
pellet was washed twice in ice-cold wash buffer containing 50 mM Tris HCl (pH
8.0), 20 mM EDTA, 10 mM benzamidine, and 1 mg of leupeptin per ml. The final
cell pellet was suspended in 300 ml of the wash buffer and sonicated. Extracellular material or spent culture medium was obtained by removing the cells by
centrifugation (12,000 3 g, 5 min, 48C) and harvesting the supernatant. A portion
of spent medium was concentrated approximately 10-fold by the addition of a
saturated solution of ammonium sulfate to a final concentration of 55%. After a
2-h incubation on ice, precipitated extracellular proteins were collected by centrifugation (12,000 3 g, 15 min, 48C). Samples for SDS-PAGE (11% gel) and
immunoblot analysis were normalized to the A540 reading at the time of harvest,
suspended in SDS sample buffer, and boiled for 5 min in the presence of
2-mercaptoethanol. Lanes were loaded with 5 ml of each extract, which represented a 13 concentration of whole culture, cellular lysate, or supernatant, or
103 concentrated supernatant. Immunoblot analysis was performed with a rabbit-specific antiserum raised against both the 49-kDa and the 53-kDa forms of
exoenzyme S (9) as the probe and 125I-labeled protein A as the secondary
reagent, as described previously (10).
O serotyping. O serotyping was performed at the Statens Seruminstitut as
described by Liu et al. (21).
Degradation of 3,5-dichlorobenzoate. P. aeruginosa AC869 and AC869-11
were grown on M9 minimal medium agar plates containing 1 mg of 3,5-dichlorobenzoate per ml (added to 1 liter as 1 g dissolved in 1 ml of dimethyl sulfoxide
[Aldrich Chemical Co., Milwaukee, Wis.]). M9 agar medium with dimethyl
sulfoxide (1 ml/liter) was used as a negative control. Purified agar (12 g/liter;
Sigma) was used in making all M9 plates. Plates were inoculated with 107
CFU/plate and incubated at 308C. At 24-h intervals, over a 72-h period, bacteria
were removed from a set of plates with a sterile spreading rod after adding 5 ml
of sterile saline to each plate. Samples were read for A600 and plated on L agar
plates for viable counts. L agar plates were incubated at 378C for 24 h prior to
counting.
Survival in 3,5-dichlorobenzoate-contaminated soil. Cultures of AC869 and
AC869-11 were grown at 378C overnight in LB with vigorous aeration, washed
twice separately in sterile water, and resuspended separately at a concentration
of 4.0 3 107 per ml in 80 ml of sterile water containing 1 mg of 3,5-dichlorobenzoate per ml. Three 25-ml aliquots of AC869 were added to three separate
100-g samples of sterile surface soil-(collected from surface soil used for growing
turf at the University of Rhode Island) in 250-ml Erlenmeyer flasks. Three other
100-g samples of sterile soil were inoculated with three 25-ml aliquots of AC86911. Soil cultures were incubated at 248C for various times, and 5-g samples were
taken into 5 ml of 0.9% (wt/vol) NaCl, vortexed, and plated on L agar plates.
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probed with CM-anti-AC869 serum on blots (Fig. 3). LPS
isolated from AC869 grown in CM and LM (Fig. 3, lanes 3 and
4) contained a definite stepladder configuration which was not
detectable in LPS isolated from AC869 grown in LB (Fig. 3,
lane 2). High-molecular-weight clusters of bands were observed in all three LPS preparations, but the intensities of
these clusters were highest in LPS preparations isolated from
LM- and CM-grown cells (Fig. 3).
It was possible that something in CM and LM induced O
side chain synthesis or that L broth inhibited O side chain
synthesis. Therefore, lung mucus was collected from the lungs
of CD-1 mice in L broth and AC869 was grown in L broth and
L broth supplemented with lung mucus (1 mg of protein per
ml). LPS was extracted from both cultures, and equal amounts
were tested for the stepladder configuration on blots probed
with CM-anti-AC869 serum. LPS isolated from the mucussupplemented L broth culture contained a definite stepladder
configuration and intense high-molecular-weight clusters of
bands whereas the LPS isolated from the L broth culture did

FIG. 3. Immunoblot of LPS isolated from AC869 and AC869-11 probed with
CM-anti-AC869 serum. LPS was extracted from strains AC869 and AC869-11
grown in LB, CM, and LM. LPS (0.03 mg of KDO) from each sample was
subjected to SDS-PAGE, and a blot was probed with CM-anti-AC869 serum.
Lane 1, protein standards; lane 2, AC869 LPS from LB-grown cells; lane 3,
AC869 LPS from CM-grown cells; lane 4, AC869 LPS from LM-grown cells; lane
5, AC869-11 LPS from LB-grown cells; lane 6, AC869-11 LPS from CM-grown
cells; lane 7, AC869-11 LPS from LM-grown cells. Numbers at left are molecular
masses in kilodaltons.

FIG. 4. Survival of mice infected with AC869 and AC869-11. AC869 and
AC869-11 were administered intranasally at the indicated doses as described in
Materials and Methods. Symbols: å, AC869; Ç, AC869-11.

not (not shown), suggesting that lung mucus contains an inducer of O side chain synthesis.
Isolation and testing of LPS mutants in mice. Because
AC869 synthesized more O6 when grown in CM and LM than
when grown in LB, it became of great interest to isolate LPS
mutants of AC869 and determine the effect on pathogenesis.
Using phage E79, which adsorbs to O side chain (16), we were
able to isolate E79-resistant AC869 mutants. Six E79-resistant
mutants were selected for testing in mice. Each mutant (2 3
108 CFU) was administered to three CD-1 mice intranasally.
Strain AC869 and PBS were used as controls. Five of the six
mutants appeared to be as virulent as their parent, killing all
three mice overnight, but the sixth, designated AC869-11,
killed only one mouse and that mouse died at least 8 h later
than the mice infected with the other five mutants. The other
two mice infected with AC869-11 appeared ruffled and lethargic for 2 days but then regained a normal, healthy appearance
and survived indefinitely. All three mice treated with PBS
survived and appeared healthy throughout the duration of the
experiment. A more detailed study of AC869-11 pathogenesis
was then undertaken.
LD50s. The LD50s of AC869 and AC869-11 were determined. Five animals were used at each dose for each strain in
each experiment, and the data derived from two separate experiments were combined and are presented. The LD50s of
strains AC869 and AC869-11 were found to be 1.91 3 108
and 1.55 3 109 CFU, respectively (Fig. 4); i.e., the LD50 of
AC869-11 was about nine times higher than that of AC869.
The correlation coefficients of the LD50s of strains AC869 and
AC869-11 were both 0.82. The LD50 of AC869 reported here
is about 10-fold higher than that reported previously (11),
presumably because in the present case the mice were not
starved prior to infection.
Clearance from the lungs, small intestine, cecum, large intestine, liver, spleen, and mesenteric lymph nodes. A nonlethal
dose of AC869 and AC869-11 (107 CFU) was administered
intranasally to CD-1 mice, and the mice were monitored for 14
days following treatment. Lungs, small intestine, cecum, large
intestine, liver, spleen, and mesenteric lymph nodes were examined. At 3 h postadministration, 107 CFU of AC869 was
found per g of lung tissue, whereas only 105 CFU per g of lung
tissue of AC869-11 was found in the lungs at the same time
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FIG. 2. Silver stain of AC869 and AC869-11 LPS preparations. LPS was
extracted from strains AC869 and AC869-11 grown in LB, CM, and LM. LPS
(0.03 mg of KDO) from each sample was subjected to SDS-PAGE and silver
stained. Lane 1, protein standards; lane 2, AC869 LPS from LB-grown cells; lane
3, AC869 LPS from CM-grown cells; lane 4, AC869 LPS from LM-grown cells;
lane 5, AC869-11 LPS from LB-grown cells; lane 6, AC869-11 LPS from CMgrown cells; lane 7, AC869-11 LPS from LM-grown cells. Arrowheads indicate
positions of high-molecular-weight LPS molecules. Numbers at left are molecular masses in kilodaltons.
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TABLE 1. MICs and MBCs of P. aeruginosa AC869
and AC869-11 in LMa
Value for P. aeruginosa strain:
Antibiotic

Ampicillin
Carbenicillin
Chloramphenicol
Gentamicin
Kanamycin
Nalidixic acid
Neomycin
Streptomycin
Tetracycline
a

AC869

AC869-11

MIC

MBC

MIC

MBC

4,000
31.25
200
6.25
250
50
50
25
25

4,000
31.25
400
12.50
250
200
50
25
50

250
31.25
200
6.25
62.5
50
6.25
6.25
6.25

1,000
62.50
400
6.25
125
400
6.25
6.25
12.5

MICs and MBCs are expressed in micrograms per milliliter.

resistance of the two strains to chloramphenicol and carbenicillin (Table 1).
Extracellular protease activity. AC869 and AC869-11 were
grown standing in LB for 24 h at 378C. Ten microliters of the
cell-free supernatants of the AC869 and AC869-11 LB-grown
cultures and twofold serial dilutions of the cell-free supernatants were pipetted onto casein agar plates. Extracellular protease activity (a clear zone on casein agar plates) was observable at dilutions of the AC869 supernatant as high as 16-fold,
but not at 32-fold. There was no protease activity in either the
undiluted or the diluted LB AC869-11 supernatants. Therefore, AC869 grown in LB contained at least 16 times as much
extracellular protease activity as did AC869-11 grown in LB.
That AC869-11 makes some protease was shown by toothpicking from colonies on L agar to casein agar plates. After incubation for 24 h at 378C; small zones of casein hydrolysis surrounding the colonies were observed.
Exoenzyme S activity. Exoenzyme S, a P. aeruginosa ADPribosyltransferase, has been implicated in tissue damage (24).
To determine whether exoenzyme S production was altered in
AC869-11, it and AC869 were grown under inducing (with
NTA) and noninducing (without NTA) conditions for exoenzyme S synthesis and ADP-ribosyltransferase assays were performed with extracellular samples. In the presence of NTA,
AC869-11 demonstrated about a twofold reduction in extracellular exoenzyme S activity relative to AC869 (22.19 6 1.73
U versus 40.19 6 17.7 U, respectively). In the absence of NTA,
essentially no exoenzyme S activity was observed (0.06 6 0.06
U for AC869 and 0.06 6 0.02 U for AC869-11). These results
suggested that AC869-11 has a defect in the ability to either
synthesize or secrete active exoenzyme S.
To determine if the reduction in exoenzyme S activity correlated with a reduction in the amount of exoenzyme S protein
produced by AC869-11, immunoblot analysis was performed
with antigens prepared from AC869 and AC869-11 (Fig. 5)
and antisera specific for exoenzyme S (9). The pattern of exoenzyme S antigen production correlated with the enzyme
activity analysis, as the amount of immunoreactive products
appeared to be reduced in each fraction of AC869-11 compared to AC869 (Fig. 5). Exoenzyme S was secreted in both
strains. Moreover, the proportion of immunoreactive material
that was cell associated (Fig. 5, lanes 2 and 6) and extracellular
(Fig. 5, lanes 3 and 7) appeared to be approximately equal in
AC869 and AC869-11. These data indicate that the mutation
in AC869-11 did not alter exoenzyme S secretion but appeared
to be related to the synthesis of exoenzyme S.
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(not shown). Thereafter, the two strains appeared to be
cleared at the same rate; however, AC869-11 was completely
cleared from the lungs by day 5 postadministration, whereas
some of AC869 (about 10 CFU per g of lung tissue) still
remained (not shown). AC869 persisted in the small intestine,
cecum, and large intestine for 10 to 14 days at about 102 CFU
per g of tissue, and AC869 was found in the spleen, liver, and
mesenteric lymph nodes at 3 h postadministration in fairly high
numbers (about 103 CFU per g of tissue for each tissue), but
not thereafter (not shown). In contrast, AC869-11 was observed only at 3 h postadministration in the small intestine,
cecum, and large intestine but at levels 1,000-fold below that of
AC869 (i.e., 101 CFU per g of tissue for AC869-11 versus 104
CFU per g of tissue for AC869) and was not found in spleen,
liver, and mesenteric lymph nodes throughout the duration of
the experiment (not shown).
Pulmonary inflammatory response. One day following intranasal treatment with 107 CFU of either AC869 or AC869-11
and at intervals thereafter for 14 days, cells were collected
from the lungs by bronchoalveolar lavage. Although both
AC869 and AC869-11 caused inflammation in the lungs for 2
days as judged by neutrophil infiltration, the inflammatory
response induced by AC869-11 (8.0 3 105 neutrophils per ml
of lung lavage fluid) was about fourfold less than that induced
by AC869 (3.4 3 106 neutrophils per ml of lung lavage fluid) on
day 2 postinfection. Neutrophils were not found in the lung
lavage fluid of PBS-treated control mice.
Growth of AC869 and AC869-11 in LM, CM, and LB. The
observed attenuation of AC869-11 relative to AC869 might be
explained if AC869-11 grew more slowly in lung mucus than
did AC869. However, the kinetics of growth (doubling times of
about 44 min) and the final yields of AC869 and AC869-11
(about 109 CFU per ml) were identical. Growth rates and
growth yields of the two strains in CM and LB were essentially
identical to growth rates and growth yields in LM.
Immunoblot of P. aeruginosa AC869 and AC869-11 whole
cells probed with CM-anti-AC869 serum. When LB-, CM-, and
LM-grown cells were examined by immunoblotting with CManti-AC869 serum as the probe, the stepladder configuration
which was observed in CM- and LM-grown AC869 was still
observable in CM- and LM-grown AC869-11 but was far less
intense than that observed with AC869 (not shown), suggesting
that AC869-11 makes some O side chain when grown in CM
and LM, but far less than does AC869.
Immunoblot of LPS isolated from AC869-11 probed with
CM-anti-AC869 serum. LPS isolated from AC869-11 grown in
LB, CM, and LM was probed with CM-anti-AC869 serum.
Stepladder configurations were not observed, although faint
traces of high-molecular-weight clusters were visible (Fig. 3,
lanes 5, 6, and 7). However, the high-molecular-weight clusters
were not visible when LPSs isolated from AC869-11 grown in
LB, CM, and LM were silver stained (Fig. 2, lanes 5, 6, and 7).
These data also suggest that AC869-11 is a mutant which
contains some O side chain in CM and LM, but far less than
strain AC869 under the same conditions.
Antibiotic sensitivity. AC869 and AC869-11 were grown in
LM and LB containing different concentrations of antibiotics
as described in Materials and Methods. MICs and MBCs were
determined for the following antibiotics: b-lactams (ampicillin
and carbenicillin), aminoglycosides (gentamicin, kanamycin,
neomycin, and streptomycin), quinolones (nalidixic acid), tetracycline, and chloramphenicol. In both LM (Table 1) and LB
(not shown), AC869-11 was more sensitive to ampicillin, gentamicin, kanamicin, neomycin, streptomycin, and tetracycline
than was AC869 (Table 1). AC869-11 was more resistant to
nalidixic acid than was AC869. There was no difference in the
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Degradation of 3,5-dichlorobenzoate. To determine whether
the mutation in AC869-11 altered its ability to degrade 3,5dichlorobenzoate, strains were inoculated (107 CFU/plate) on
M9 minimal medium agar plates containing 3,5-dichlorobenzoate (1 mg/ml) as sole carbon and energy source and were
incubated at 308C (see Materials and Methods). AC869-11
grew at the same rate as AC869 on M9 agar plates containing
3,5-dichlorobenzoate (8-h average doubling time) and to the
same extent (5 3 109 CFU/plate at 72 h) but did not grow on
M9 agar plates in the absence of a carbon source. Moreover,
when AC869 and AC869-11 were spotted onto M9 agar medium containing 3,5-dichlorobenzoate as a carbon source and
bromthymol blue as an acid-base indicator, both turned yellow
after 2 days of incubation at 308C, indicating acid production
during growth. These data indicate that strains AC869-11 and
AC869 utilize 3,5-dichlorobenzoate as the sole carbon and
energy source equally well. As a control, P. aeruginosa PAO1
was tested for its ability to utilize 3,5-dichlorobenzoate for
growth. PAO1 grew on M9 agar plates containing glucose (1
mg/ml) as the sole carbon source but not on M9 plates containing 3,5-dichlorobenzoate.
Survival in 3,5-dichlorobenzoate-contaminated soil. AC869
and AC869-11 were inoculated into 3,5-dichlorobenzoate-contaminated soil (0.25 mg/g) at a level of 1.0 3 107 CFU/g (see
Materials and Methods). Both strains survived equally well for
approximately 1 week; however, thereafter AC869 persisted in
soil at levels ranging between 104 and 106 CFU/g, as observed
previously for P. aeruginosa (30), whereas the level of AC86911 decreased continually until it was virtually undetectable
(Fig. 6).
DISCUSSION
The goal of this study was to attenuate P. aeruginosa AC869
in mice without hampering its ability either to degrade 3,5dichlorobenzoate or to survive in the environment. Our approach was to grow AC869 in mouse lung mucus, mouse cecal
mucus, and LB and determine whether mutants unable to
make antigens expressed exclusively in lung and cecal mucus
would lead to attenuation of AC869. We found that AC869
made far more O side chain on its LPS when grown in both
lung and cecal mucus than when grown in LB and were able to
isolate mutants that made little, if any, O side chain under
these conditions. Five of six mutants tested appeared to be as
virulent as AC869 when administered to mice intranasally, suggesting that lack of O side chain was not sufficient for attenuation in the lungs of CD-1 mice. However, the sixth mutant
tested, AC869-11, had an LD50 that was ninefold higher than

FIG. 6. Survival of AC869 and AC869-11 in 3,5-dichlorobenzoate-contaminated soil. Soil samples contaminated with 3,5-dichlorobenzoate were inoculated
with either AC869 (■) or AC869-11 (å) and sampled at the indicated times as
described in Materials and Methods. Error bars represent the standard errors of
the log10 mean CFU per gram of soil.
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FIG. 5. Immunoblot analysis of cellular fractions of AC869 and AC869-11
for exoenzyme S antigen production. Samples were prepared as described in
Materials and Methods from cultures grown under inducing conditions for exoenzyme S production. wc, whole culture; c, cellular lysate; sn, spent medium or
culture supernatant; 103 sn, spent medium concentrated 10-fold by ammonium
sulfate precipitation. The migration of the 49-kDa form of exoenzyme S is
labeled.

that of AC869 (Fig. 4) but grew as well as AC869 with 3,5dichlorobenzoate as the sole carbon and energy source.
AC869-11 not only has less O side chain than AC869 on its
surface but is defective in either synthesis or transport of extracellular proteases, which have been implicated in tissue destruction (1). Moreover, AC869-11 is far more sensitive to a
number of antibiotics than is AC869 (Table 1). Changes in
susceptibility to antibiotics in undefined P. aeruginosa LPS
mutants have been noted previously (17, 18). If the defect in
AC869-11 is in transport, it could be in a gene encoding a
protein common to and necessary for the export of LPS, extracellular protease, and antibiotics through the membrane. In
this case, the mutation in P. aeruginosa AC869-11 would cause
several export systems to be less functional and would result in
diminished secretion of virulence factors and decreased efflux
of antibiotics, without affecting their influx. P. aeruginosa is
known to have at least one efflux system for antibiotics, which
contributes to its naturally high resistance (25). At the present
time, however, we favor the hypothesis that P. aeruginosa
AC869-11 is defective in regulation of expression of several
virulence genes, since it made far less exoenzyme S than
AC869 but appeared to secrete it normally (Fig. 5).
AC869-11 degraded 3,5-dichlorobenzoate as well as AC869
under controlled laboratory conditions. However, AC869-11
did not survive in 3,5-dichlorobenzoate-contaminated sterile
soil as well as AC869 after 1 week (Fig. 6). Therefore, in the
present case, it appears that the mutation which resulted in
attenuation of P. aeruginosa AC869-11 in the lungs of CD-1
mice also resulted in attenuation of its ability to survive in soil.
To our knowledge (by use of the Medline Express [1966 to
1996] database), the present study is the only one in which an
attempt has been made to isolate a P. aeruginosa mutant that
is attenuated when administered intranasally to mice and to
determine whether it remains strong in the environment.
Whether it is a general rule that mutations resulting in pulmonary attenuation of P. aeruginosa also result in weakness in the
environment remains to be seen. It should be noted, however,
that despite weakness in the environment, strains like AC86911 may prove to be useful in bioreactors, under controlled
conditions, in which they remain fully capable of degrading
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toxic compounds without posing a serious threat to human
health.
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